Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia: A multicenter report from the Campus ALL Network

M.I.D. Principe, E. Buzzatti, A. Piciocchi, F. Forghieri, M. Bonifacio, F. Lessi, S. Imbergamo, E. Orciuolo, G. Rossi, N. Fracchiolla, S. Trappolini, B. Neri, C. Sarlo, P. Zappasodi, M. Dargenio, M. Cefalo, M.A. Irno-Consalvo, C. Conti, G. Paterno, G. De AngelisM. Sciumè, I.D. Starza, A. Venditti, R. Foà, A.R. Guarini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)39-45
Number of pages7
JournalHaematologica
Volume106
Issue number1
DOIs
Publication statusPublished - 2021

Keywords

  • CD19 antibody
  • CD20 antigen
  • common acute lymphoblastic leukemia antigen
  • cytarabine
  • dexamethasone
  • methotrexate
  • methylprednisolone
  • steroid
  • acute lymphoblastic leukemia
  • adult
  • aged
  • allogeneic stem cell transplantation
  • Article
  • cancer chemotherapy
  • cancer mortality
  • cancer prevention
  • cancer recurrence
  • cancer survival
  • central nervous system
  • central nervous system disease
  • cerebrospinal fluid
  • cerebrospinal fluid analysis
  • clinical outcome
  • cytogenetics
  • cytology
  • disease free survival
  • erythrocyte count
  • female
  • flow cytometry
  • follow up
  • human
  • incidence
  • lactate dehydrogenase blood level
  • leukocyte count
  • lumbar puncture
  • major clinical study
  • male
  • multiple cycle treatment
  • overall survival
  • phenotype
  • protein cerebrospinal fluid level
  • recurrence risk
  • retrospective study
  • treatment response
  • clinical trial
  • multicenter study
  • recurrent disease
  • Adult
  • Central Nervous System Diseases
  • Flow Cytometry
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Recurrence
  • Retrospective Studies

Cite this